Modified allelic replication in lymphocytes of patients with neurofibromatosis type 1

Cancer Genetics and Cytogenetics

Volumn 143, Issue 2, 2003, Pages 133-139

  Reish, Orit ^a,b   Orlovski, Ana ^a,c   Mashevitz, Maya ^a   Sher, Carron ^a   Libman, Vitalia ^a   Rosenblat, Malka ^a   Avivi, Lydia ^b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER GENETICS; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE REPLICATION; HUMAN; HUMAN CELL; LYMPHOCYTE; NEUROFIBROMATOSIS; PRIORITY JOURNAL;

EID: 0038054377     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00858-0     Document Type: Article

References (39)

1. Ben-Porath I., Cedar H. Imprinting focusing on the center. Curr Opin Gen Dev. 10:2000;550-554.
2. Simon I., Tenzen T., Mostoslavsky R., Fibach E., Lande L., Milot E., Gribnau J., Grosveld F., Fraser P., Cedar H. Development regulation of DNA replication timing at the human β globin locus. EMBO J. 20:2001;6150-6157.
3. Selig S., Okumura K., Ward D.C., Cedar H. Delineation of DNA replication time zones by fluorescence in situ hybridization. EMBO J. 11:1992;1217-1225.
4. Gunaratne P.H., Nakao M., Ledbetter D.H., Sutcliffe J.S., Chinault A.C. Tissue-specific and allele-specific replication timing control in the imprinted human Prader-Willi syndrome region. Genes Dev. 9:1995;808-820.
5. Yeshaya J., Shalgi R., Shohat M., Avivi L. Replication timing of the various FMR1 alleles detected by FISH. inferences regarding their transcriptional status Hum Genet. 102:1998;6-14.
6. Mostoslavsky R., Singh N., Tenzen T., Goldmit M., Gabay C., Elizur S., Qi P., Reubinoff B.E., Chess A., Cedar H. Asynchronous replication and allelic exclusion in the immune system. Nature. 414:2001;221-225.
7. Lyon M.F. The William Allan Memorial Award Address. X-chromosome inactivation and the localization and expression of X-linked genes Am J Hum Genet. 42:1988;8-16.
8. Willard H.F. Sex chromosomes and X chromosome inactivation. Scriver C.K., Beaudet A.L., Sly W.S., Valle D. The etabolic and molecular bases of inherited disease. 7th edition:1995;719-737 McGraw-Hill; New York.
9. Torchia B.S., Call L.M., Migeon B.R. DNA replication analysis of FMR1, XIST, and factor 8C loci by FISH shows nontranscribed X-linked genes replicate late. Am J Hum Genet. 55:1994;96-104.
10. Boggs B., Chinault C. Analysis of the replication timing properties of human X-chromosomal loci by fluorescence in-situ hybridization. Proc Natl Acad Sci USA. 91:1994;6083-6087.
11. Kitsberg D., Selig S., Brandeis M., Simon I., Keshet I., Driscoll D.J., Nicholls R.D., Cedar H. Allele-specific replication timing of imprinted gene regions. Nature. 364:1993;459-463.
12. Knoll J.H.M., Cheng S.D., Lalande M. Allele specificity of DNA replication timing in the Angelmann/Prader-Willi syndrome imprinted chromosomal region. Nat Genet. 6:1994;41-46.
13. White L.M., Rogan P.K., Nicholls R.D., Wu B.L., Korf B., Knoll J.H.M. Allele specific replication of 15q11-q13 loci. a diagnostic test for uniparental disomy Am J Hum Genet. 59:1996;423-430.
14. Chess A. Expansion of the allelic exclusion principle? Science. 9:1998;2067-2068.
15. Boggs B.A., Chinault A.C. Analysis of DNA replication by fluorescence in situ hybridization. Methods. 13:1997;259-270.
16. Simon I., Tenzen T., Reubinoff B.E., Hillman D., McCarrey J.R., Cedar H. Asynchronous replication of imprinted genes is established in the gametes and maintained during development. Nature. 401:1999;929-932.
17. Subramanian P.S., Nelson D.L., Chinault A.C. Large domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and FRAXE. Am J Hum Genet. 59:1996;407-416.
18. Amiel A., Litmanovitch T., Gaber E., Lishner M., Avivi L., Fejgin M. Asynchronous replication of p53 and 21q22 loci in chronic lymphocytic leukemia. Hum Genet. 101:1997;219-222.
19. Amiel A., Litmanovitch T., Lishner M., Mor A., Gaber E., Fejgin M.D., Avivi L. Temporal differences in replication timing of homologous loci in malignant cells derived from CML and lymphoma patients. Genes Chromosomes Cancer. 22:1998;225-231.
20. Korenstein-Ilan A, Amiel A, Lalezari S, Lishner M, Avivi L. Allele specific replication associated with aneuploidy in blood cells of patients with hematological malignancies. Cancer Genet Cytogenet, in press.
21. Korenstein-Ilan A, Amiel A, Lalezari S, Lishner M, Avivi L. Allele specific replication associated with aneuploidy in blood cells of patients with hematological malignancies. Cancer Genet Cytogenet, in press.
22. Dotan Z.A., Dotan A., Litmanovitch T., Ravia Y., Oniasvili N., Leibovitch I., Ramon J., Avivi L. Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma. a novel genetic alteration associated with malignancy Genes Chromosomes Cancer. 27:2000;270-277.
23. Amiel A., Kirgner I., Gaber E., Manor Y., Fejgin M., Lishner M. Replication pattern in cancer. asynchronous replication in multiple myeloma and in monoclonal gammopathy Cancer Genet Cytogenet. 108:1999;32-37.
24. Amiel A., Kitay-Cohen Y., Fejgin M.D., Lishner M. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol. 28:2000;156-160.
25. Huson S.M., Compston D.A.S., Clark P., Harper P.S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 16:1989;704-711.
26. Voutsinas S., Wynne-Davies R. The infrequency of malignant disease in diaphyseal aclasis and neurofibromatosis. J Med Genet. 20:1983;345-349.
27. Ledbetter D.H., Rich D.C., O'Connell P. Precise localization of NF1to 17q11.2 by balanced translocation. Am J Hum Genet. 44:1989;20-24.
28. O'Connell P., Leach R., Cawthon R.M., Culver M., Stevens J., Viskochil D., Fournier R.E.K., Rich D.C., Ledbetter D.H., White R. Two NF1 translocations map within a 600-kilobase segment of 17q11.2. Science. 244:1989;1087-1088.
29. Li Y., O'Connell P., Breidenbach N.H., Cawthon R., Stevens J., Xu G., Neil S., Robertson M., White R., Viskochil D. Genomic organization of the neurofibromatosis I gene (NF1). Genomics. 25:1995;9-18.
30. Cawthon R.M., O'Connell P., Buchberg A.M., Viskochil D., Weiss R.B., Culver M., Stevens J., Jenkins N.A., Copeland N.G., White R. Identification and characterization region of transcripts from the neurofibromatosis 1 region. the sequence and genomic structure of EV12 and mapping of other transcripts Genomics. 7:1990;555-565.
31. Gutmann D.H., Collins F.S. Neurofibromatosis type 1. Vogelstein B., Kinzler K.W. The genetic basis of human cancer. 1998;423-442 McGraw-Hill, New York.
32. Glover T.W., Stein C.K., Legius E., Andersen L.B., Brereton A., Johnson S. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Gene Chromosomes Cancer. 3:1991;62-70.
33. Seizinger B.R. NF1. a prevalent cause of tumorigenesis in human cancer Nat Genet. 3:1993;97-99.
34. National Institute of Health. Consensus development conference statement: Neurofibromatosis. Bethesda, MD, USA, July 13-15, 1987. Neurofibromatosis 1988;1:172-8.
35. National Institute of Health. Consensus development conference statement: Neurofibromatosis. Bethesda, MD, USA, July 13-15, 1987. Neurofibromatosis 1988;1:172-8.
36. Mueller B.U., Pabst T., Osato M., Asou N., Johansen L.M., Minden M.D., Behre G., Hiddemann W., Ito Y., Tenen D.G. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood. 100:2002;998-1007.
37. Park M. Oncogenes. Vogelstein B., Kinzler K.W. The genetic basis of human cancer. 1998;205-228 McGraw-Hill, New York.
38. Luijten M., Redeker S., Minoshima S., Shimizu N., Westerveld A., Hulsebos T.J.M. Duplication and transposition of the NF1 pseudogene regions on chromosomes 2, 14, and 22. Hum Genet. 109:2001;109-116.
39. Osborn M.J., Upadhyaya M. Evaluation of the protein truncation test and mutation detection in the NF1 gene. mutational analysis of 15 known and 40 unknown mutations Hum Genet. 105:1999;327-332.